Go Pro

William Woods Analyst Performance

Analyst at B. Riley Financial

William Woods is a stock analyst at B. Riley Financial focused in the medical sector, covering 10 publicly traded companies. Over the past year, William Woods has issued 10 stock ratings, including and buy recommendations. While full access to William Woods' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights William Woods' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
12 Last 1 Years
Buy Recommendations
100.00% 12 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%12 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
10 companies

William Woods, an analyst at B. Riley Financial, currently covers 10 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
9 companies
90.0%
Manufacturing
1 company
10.0%

William Woods of B. Riley Financial specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
6 companies
60.0%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
1 company
10.0%
MEDICAL INFO SYS
1 company
10.0%
MED - DRUGS
1 company
10.0%
MEDICAL SERVICES
1 company
10.0%

William Woods' Ratings History at B. Riley Financial

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
AgomAb Therapeutics NV stock logo
AGMB
AgomAb Therapeutics
7/23/2026Initiated Coverage$11.60$34.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
5/22/2026Lower Price Target$13.15$27.00Buy
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
5/15/2026Lower Price Target$5.17$7.00Buy
Equillium, Inc. stock logo
EQ
Equillium
4/16/2026Initiated Coverage$2.03$6.00Buy
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
3/13/2026Boost Price Target$4.36$8.00Buy
Altimmune, Inc. stock logo
ALT
Altimmune
3/6/2026Lower Price Target$3.70$13.00Buy
Palisade Bio, Inc. stock logo
PALI
Palisade Bio
1/9/2026Initiated Coverage$1.90$7.00Buy
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
12/8/2025Initiated Coverage$1.91$5.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
11/21/2025Reiterated Rating$1.34$3.00Buy
LifeMD, Inc. stock logo
LFMD
LifeMD
11/18/2025Lower Price Target$3.75$10.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
5/23/2025Reiterated Rating$9.14$50.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
4/16/2025Reiterated Rating$9.59$60.00Buy